
Global Peritoneal Dialysis Market
Description
Global Peritoneal Dialysis Market size was valued at USD 9.25 billion in 2023 and is poised to grow from USD 10 billion in 2024 to USD 18.47 billion by 2032, growing at a CAGR of 8% during the forecast period (2025-2032)
The peritoneal dialysis (PD) market is experiencing significant growth, driven by its advantages over traditional hemodialysis, such as increased flexibility and reduced need for medical assistance. This home-based treatment is particularly beneficial for patients with some renal function, allowing for continuous self-monitoring and minimal dietary restrictions. Despite challenges related to patient accessibility and technological familiarity, the uptick in home dialysis usage has been notable, rising from 14.8% to 20% for patients with end-stage kidney disease (ESKD) under two years and from 11.7% to 13.7% for those between two to four years. The COVID-19 pandemic accelerated demand for dialysis supplies, and ongoing advancements in medical technology and growing support for home treatments will further enhance market opportunities moving forward.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Peritoneal Dialysis Market Segments Analysis
Global Peritoneal Dialysis Market is segmented by offering, modality, disease indication, end user and region. Based on offering, the market is segmented into peritoneal dialysis products and peritoneal dialysis services. Based on modality, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on disease indication, the market is segmented into end-stage renal disease, acute kidney injury and other diseases. Based on end user, the market is segmented into home care settings, hospitals & independent dialysis centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Peritoneal Dialysis Market
The global peritoneal dialysis market is expected to experience significant growth during the projected period, driven by several key factors. The increasing prevalence of end-stage renal disease (ESRD), coupled with advancements in peritoneal dialysis technology, particularly in cyclers, is anticipated to boost market demand. Additionally, the rising preference for home dialysis treatment reflects a shift towards more patient-centered care. Peritoneal dialysis offers various advantages, such as lower costs compared to hemodialysis, a needle-free approach, enhanced mobility, user-friendly treatment processes, and fewer dietary limitations, all of which contribute to the market's international expansion.
Restraints in the Global Peritoneal Dialysis Market
The global peritoneal dialysis market faces several significant challenges that hinder its growth. Among the primary obstacles are the heightened risk of infections and treatment failures associated with the procedure, as well as complications arising from the need for permanent catheter insertion through the skin. Additionally, the complex regulatory processes required for the approval of new dialysis devices further impede innovation and market expansion. These factors contribute to the overall limitations faced by the market, making it more difficult for healthcare providers and patients to fully utilize the benefits of peritoneal dialysis as a treatment option.
Market Trends of the Global Peritoneal Dialysis Market
The global peritoneal dialysis market is poised for substantial growth, driven by several key factors including the rising incidence of End-Stage Renal Disease (ESRD), alongside the growing prevalence of diabetes and hypertension. Increased public awareness about peritoneal dialysis options, coupled with proactive governmental initiatives aimed at improving access to renal care, further stimulate market expansion. Furthermore, there is a shift towards adopting advanced technological treatment solutions, enhancing patient outcomes. Notably, developing nations, particularly China and India, are carving out significant market opportunities as they embrace peritoneal dialysis, illustrating a robust upward trend in global demand for this essential renal therapy.
The peritoneal dialysis (PD) market is experiencing significant growth, driven by its advantages over traditional hemodialysis, such as increased flexibility and reduced need for medical assistance. This home-based treatment is particularly beneficial for patients with some renal function, allowing for continuous self-monitoring and minimal dietary restrictions. Despite challenges related to patient accessibility and technological familiarity, the uptick in home dialysis usage has been notable, rising from 14.8% to 20% for patients with end-stage kidney disease (ESKD) under two years and from 11.7% to 13.7% for those between two to four years. The COVID-19 pandemic accelerated demand for dialysis supplies, and ongoing advancements in medical technology and growing support for home treatments will further enhance market opportunities moving forward.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Peritoneal Dialysis Market Segments Analysis
Global Peritoneal Dialysis Market is segmented by offering, modality, disease indication, end user and region. Based on offering, the market is segmented into peritoneal dialysis products and peritoneal dialysis services. Based on modality, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on disease indication, the market is segmented into end-stage renal disease, acute kidney injury and other diseases. Based on end user, the market is segmented into home care settings, hospitals & independent dialysis centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Peritoneal Dialysis Market
The global peritoneal dialysis market is expected to experience significant growth during the projected period, driven by several key factors. The increasing prevalence of end-stage renal disease (ESRD), coupled with advancements in peritoneal dialysis technology, particularly in cyclers, is anticipated to boost market demand. Additionally, the rising preference for home dialysis treatment reflects a shift towards more patient-centered care. Peritoneal dialysis offers various advantages, such as lower costs compared to hemodialysis, a needle-free approach, enhanced mobility, user-friendly treatment processes, and fewer dietary limitations, all of which contribute to the market's international expansion.
Restraints in the Global Peritoneal Dialysis Market
The global peritoneal dialysis market faces several significant challenges that hinder its growth. Among the primary obstacles are the heightened risk of infections and treatment failures associated with the procedure, as well as complications arising from the need for permanent catheter insertion through the skin. Additionally, the complex regulatory processes required for the approval of new dialysis devices further impede innovation and market expansion. These factors contribute to the overall limitations faced by the market, making it more difficult for healthcare providers and patients to fully utilize the benefits of peritoneal dialysis as a treatment option.
Market Trends of the Global Peritoneal Dialysis Market
The global peritoneal dialysis market is poised for substantial growth, driven by several key factors including the rising incidence of End-Stage Renal Disease (ESRD), alongside the growing prevalence of diabetes and hypertension. Increased public awareness about peritoneal dialysis options, coupled with proactive governmental initiatives aimed at improving access to renal care, further stimulate market expansion. Furthermore, there is a shift towards adopting advanced technological treatment solutions, enhancing patient outcomes. Notably, developing nations, particularly China and India, are carving out significant market opportunities as they embrace peritoneal dialysis, illustrating a robust upward trend in global demand for this essential renal therapy.
Table of Contents
257 Pages
- 1. Introduction
- 1.1. Objectives of the Study
- 1.2. Scope of the Report
- 1.3. Definitions
- 2. Research Methodology
- 2.1. Information Procurement
- 2.2. Secondary & Primary Data Methods
- 2.3. Market Size Estimation
- 2.4. Market Assumptions & Limitations
- 3. Executive Summary
- 3.1. Global Market Outlook
- 3.2. Supply & Demand Trend Analysis
- 3.3. Segmental Opportunity Analysis
- 4. Market Dynamics & Outlook
- 4.1. Market Overview
- 4.2. Market Size
- 4.3. Market Dynamics
- 4.3.1. Drivers & Opportunities
- 4.3.2. Restraints & Challenges
- 4.4. Porters Analysis
- 4.4.1. Competitive rivalry
- 4.4.2. Threat of substitute
- 4.4.3. Bargaining power of buyers
- 4.4.4. Threat of new entrants
- 4.4.5. Bargaining power of suppliers
- 5. Key Market Insights
- 5.1. Key Success Factors
- 5.2. Degree of Competition
- 5.3. Top Investment Pockets
- 5.4. Market Ecosystem
- 5.5. Market Attractiveness Index, 2024
- 5.6. PESTEL Analysis
- 5.7. Macro-Economic Indicators
- 5.8. Value Chain Analysis
- 5.9. Pricing Analysis
- 5.10. Technology Analysis
- 5.11. Trade Analysis
- 5.12. Regulatory Analysis
- 5.13. Patent Analysis
- 5.14. Case Study Analysis
- 6. Global Peritoneal Dialysis Market Size by Offering & CAGR (2025-2032)
- 6.1. Market Overview
- 6.2. Peritoneal Dialysis Products
- 6.2.1. Peritoneal Dialysis Solution Bags
- 6.2.2. Peritoneal Dialysis Machines
- 6.2.3. Peritoneal Dialysis Catheters
- 6.2.4. Peritoneal Dialysis Transfer Sets
- 6.2.5. Other Peritoneal Dialysis Products
- 6.3. Peritoneal Dialysis Services
- 7. Global Peritoneal Dialysis Market Size by Modality & CAGR (2025-2032)
- 7.1. Market Overview
- 7.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
- 7.3. Automated Peritoneal Dialysis (APD)
- 8. Global Peritoneal Dialysis Market Size by Disease Indication & CAGR (2025-2032)
- 8.1. Market Overview
- 8.2. End-Stage Renal Disease
- 8.3. Acute Kidney Injury
- 8.4. Other Diseases
- 9. Global Peritoneal Dialysis Market Size by End User & CAGR (2025-2032)
- 9.1. Market Overview
- 9.2. Home Care Settings
- 9.3. Hospitals & Independent Dialysis Centers
- 9.4. Other End Users
- 10. Global Peritoneal Dialysis Market Size & CAGR (2025-2032)
- 10.1. North America (Offering, Modality, Disease Indication, End User)
- 10.1.1. USA
- 10.1.2. Canada
- 10.2. Europe (Offering, Modality, Disease Indication, End User)
- 10.2.1. Germany
- 10.2.2. Spain
- 10.2.3. France
- 10.2.4. UK
- 10.2.5. Italy
- 10.2.6. Rest of Europe
- 10.3. Asia Pacific (Offering, Modality, Disease Indication, End User)
- 10.3.1. China
- 10.3.2. India
- 10.3.3. Japan
- 10.3.4. South Korea
- 10.3.5. Rest of Asia-Pacific
- 10.4. Latin America (Offering, Modality, Disease Indication, End User)
- 10.4.1. Brazil
- 10.4.2. Rest of Latin America
- 10.5. Middle East & Africa (Offering, Modality, Disease Indication, End User)
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Intelligence
- 11.1. Top 5 Player Comparison
- 11.2. Market Positioning of Key Players, 2024
- 11.3. Strategies Adopted by Key Market Players
- 11.4. Recent Developments in the Market
- 11.5. Company Market Share Analysis, 2024
- 11.6. Company Profiles of All Key Players
- 11.6.1. Company Details
- 11.6.2. Product Portfolio Analysis
- 11.6.3. Company's Segmental Share Analysis
- 11.6.4. Revenue Y-O-Y Comparison (2021-2023)
- 12. Key Company Profiles
- 12.1. Fresenius Medical Care AG (Germany)
- 12.1.1. Company Overview
- 12.1.2. Business Segment Overview
- 12.1.3. Financial Updates
- 12.1.4. Key Developments
- 12.2. Baxter International Inc. (US)
- 12.2.1. Company Overview
- 12.2.2. Business Segment Overview
- 12.2.3. Financial Updates
- 12.2.4. Key Developments
- 12.3. Medtronic PLC (Ireland)
- 12.3.1. Company Overview
- 12.3.2. Business Segment Overview
- 12.3.3. Financial Updates
- 12.3.4. Key Developments
- 12.4. DaVita Inc. (US)
- 12.4.1. Company Overview
- 12.4.2. Business Segment Overview
- 12.4.3. Financial Updates
- 12.4.4. Key Developments
- 12.5. Becton, Dickinson and Company (US)
- 12.5.1. Company Overview
- 12.5.2. Business Segment Overview
- 12.5.3. Financial Updates
- 12.5.4. Key Developments
- 12.6. Terumo Corporation (Japan)
- 12.6.1. Company Overview
- 12.6.2. Business Segment Overview
- 12.6.3. Financial Updates
- 12.6.4. Key Developments
- 12.7. Utah Medical Products, Inc. (US)
- 12.7.1. Company Overview
- 12.7.2. Business Segment Overview
- 12.7.3. Financial Updates
- 12.7.4. Key Developments
- 12.8. Diaverum AB (Sweden)
- 12.8.1. Company Overview
- 12.8.2. Business Segment Overview
- 12.8.3. Financial Updates
- 12.8.4. Key Developments
- 12.9. Medionics (US)
- 12.9.1. Company Overview
- 12.9.2. Business Segment Overview
- 12.9.3. Financial Updates
- 12.9.4. Key Developments
- 12.10. Newsol Technologies Inc. (US)
- 12.10.1. Company Overview
- 12.10.2. Business Segment Overview
- 12.10.3. Financial Updates
- 12.10.4. Key Developments
- 12.11. Apollo Dialysis Pvt. Ltd. (India)
- 12.11.1. Company Overview
- 12.11.2. Business Segment Overview
- 12.11.3. Financial Updates
- 12.11.4. Key Developments
- 12.12. U.S. Renal Care, Inc. (US)
- 12.12.1. Company Overview
- 12.12.2. Business Segment Overview
- 12.12.3. Financial Updates
- 12.12.4. Key Developments
- 12.13. Northwest Kidney Centers (US)
- 12.13.1. Company Overview
- 12.13.2. Business Segment Overview
- 12.13.3. Financial Updates
- 12.13.4. Key Developments
- 12.14. Relavo (US)
- 12.14.1. Company Overview
- 12.14.2. Business Segment Overview
- 12.14.3. Financial Updates
- 12.14.4. Key Developments
- 12.15. Mitra Industries Pvt. Ltd. (India)
- 12.15.1. Company Overview
- 12.15.2. Business Segment Overview
- 12.15.3. Financial Updates
- 12.15.4. Key Developments
- 12.16. JMS Co., Ltd. (Japan)
- 12.16.1. Company Overview
- 12.16.2. Business Segment Overview
- 12.16.3. Financial Updates
- 12.16.4. Key Developments
- 12.17. Amecath (China)
- 12.17.1. Company Overview
- 12.17.2. Business Segment Overview
- 12.17.3. Financial Updates
- 12.17.4. Key Developments
- 12.18. Polymedicure (India)
- 12.18.1. Company Overview
- 12.18.2. Business Segment Overview
- 12.18.3. Financial Updates
- 12.18.4. Key Developments
- 12.19. Huaren Pharmaceutical (China)
- 12.19.1. Company Overview
- 12.19.2. Business Segment Overview
- 12.19.3. Financial Updates
- 12.19.4. Key Developments
- 12.20. Awak Technologies (Singapore)
- 12.20.1. Company Overview
- 12.20.2. Business Segment Overview
- 12.20.3. Financial Updates
- 12.20.4. Key Developments
- 13. Conclusion & Recommendations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.